Mayo Clinic Hepatobiliary SPORE

NIH RePORTER · NIH · P50 · $2,294,230 · view on reporter.nih.gov ↗

Abstract

OVERALL – PROJECT SUMMARY The Mayo Clinic Specialized Program of Research Excellence in Hepatobiliary Cancers builds upon four exceptional and diverse translational projects and three well-constructed and responsive cores that, together, promise substantial steps forward. In addition, our proposed Career Enhancement Program and Developmental Research Program are designed with the utmost support. And finally, the Mayo Clinic, the Mayo Clinic Cancer Center, and the SPORE programs, now underway at the institution, stand behind this endeavor and will provide important support toward integrating resources, skilled staff, and leadership guidance to ensure success. This confluence of expertise, resources, structure, and accountability will drive the initial five years of the HBCs SPORE to achieve its intended goals. Our approach is comprehensive and milestone-focused. We look forward to working with NCI leadership, our partners, and our patients to make this program a success.

Key facts

NIH application ID
10005922
Project number
5P50CA210964-03
Recipient
MAYO CLINIC ROCHESTER
Principal Investigator
MARK A. MC NIVEN
Activity code
P50
Funding institute
NIH
Fiscal year
2020
Award amount
$2,294,230
Award type
5
Project period
2018-09-10 → 2023-08-31